TEA means systemic filling pressures arterial- and venous resistance cardiac output fluid loading vasopressor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All adult patients scheduled for lung surgery under thoracic epidural and general anaesthesia
Exclusion criteria
Exclusion criteria: • Participation in a trial on investigational drugs within 3 months prior to the study • Hemodynamic instability prior to start of measurements with the systolic blood pressure decreasing more than 30% below the pre-anaesthetic value or a mean arterial pressure (MAP) 18 mm Hg and/ or a cardiac index < 2.0 L•min-1 or dependence on high dosages of inotropic drugs after induction of general anaesthesia and before TEA. • Severe arrhythmias • Intra-cardiac shunts • Prior diagnosis of aberrant cardiovascular anatomy • Symptomatic peripheral vascular disease • Severe chronic obstructive pulmonary disease (GOLD III or IV, or proven existence of lung bullae) • Clinically significant aortic aneurysm • Significant valvular regurgitation • Use of lithium medication • Diabetes requiring insulin therapy • On beta blocker or calcium antagonist medication • Contra-indications to epidural anaesthesia: - Increased risk of bleeding induced by medication or bleeding disorders - Local infection at the insertion site - Anatomic abnormalities of the spine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To evaluate the effects of thoracic epidural anaesthesia (TEA) under general anaesthesia on mean systemic filling pressures, arterial- and venous resistance and cardiac output | — |
Secondary
| Measure | Time frame |
|---|---|
| - To assess the hemodynamic effects of vasopressors and fluid loading under TEA with general anaesthesia conditions - To assess the value of stroke volume variation and pulse pressure variation,to predict fluid loading responsiveness with TEA. | — |
Contacts
Consultant (cardiothoracic) anaesthesiology Department of Anaesthesiology LUMC, P5Q-32 2300 RC